These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10970155)

  • 1. Influenza vaccine shortages threaten those with chronic diseases.
    SoRelle R
    Circulation; 2000 Aug; 102(8):E9014-5. PubMed ID: 10970155
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on influenza, 2004-2005.
    Schwager M; Claflin M
    Med Health R I; 2004 Oct; 87(10):311-3. PubMed ID: 15559384
    [No Abstract]   [Full Text] [Related]  

  • 3. CDC releases update on influenza activity and on composition of 1995-96 influenza vaccine.
    Am Fam Physician; 1995 Jul; 52(1):298-9. PubMed ID: 7604770
    [No Abstract]   [Full Text] [Related]  

  • 4. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 5. History of influenza vaccination programs in Japan.
    Hirota Y; Kaji M
    Vaccine; 2008 Nov; 26(50):6451-4. PubMed ID: 18573292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza immunization.
    Glück R
    Biologicals; 1997 Jun; 25(2):221-5. PubMed ID: 9236056
    [No Abstract]   [Full Text] [Related]  

  • 7. Update: influenza activity--United States and worldwide, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(38):752-5. PubMed ID: 8371709
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal versus injectable influenza vaccine.
    Genton B; D'Acremont V
    Clin Infect Dis; 2004 Sep; 39(5):754; author reply 754-5. PubMed ID: 15356796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influenza A Beijing is approaching. 2 new strains in this season's vaccine].
    Grandien M; Linde A
    Lakartidningen; 1993 Nov; 90(44):3881-3. PubMed ID: 8231547
    [No Abstract]   [Full Text] [Related]  

  • 10. [The next influenza wave is a question of time. A new variant may cause a pandemic].
    Lindberg A; Linde A; Grandien M
    Lakartidningen; 1995 Oct; 92(41):3788-9. PubMed ID: 7564630
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccine 2007-2008.
    Med Lett Drugs Ther; 2007 Oct; 49(1271):81-3. PubMed ID: 17912142
    [No Abstract]   [Full Text] [Related]  

  • 12. Public health. Who should get influenza vaccine when not all can?
    Emanuel EJ; Wertheimer A
    Science; 2006 May; 312(5775):854-5. PubMed ID: 16690847
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005.
    Can Commun Dis Rep; 2005 Sep; 31(18):181-91. PubMed ID: 16669132
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages.
    Iwane MK; Singleton JA; Walton K; Coulen C; Wooten K
    J Public Health Manag Pract; 2007; 13(3):307-13. PubMed ID: 17435498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines. Shifting tactics in the battle against influenza.
    Ault A
    Science; 2004 Feb; 303(5662):1280. PubMed ID: 14988531
    [No Abstract]   [Full Text] [Related]  

  • 17. Americans' responses to the 2004 influenza vaccine shortage.
    Desroches CM; Blendon RJ; Benson JM
    Health Aff (Millwood); 2005; 24(3):822-31. PubMed ID: 15886178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):404-9. PubMed ID: 18418347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 20. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.